Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity. [electronic resource]
Producer: 20170111Description: e785 p. digitalISSN:- 2158-3188
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.